What changed
$UNH — HOLD 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $111.7B | EPS $7.23 vs $6.60 🟢 | Margin 8.1%
💡 Consensus expects gradual estimate increases following the beat, but the market may be underestimating the durability of UNH's cost controls and diversification. A variant view is that margin improvements are sustainable, but without a clear near-term catalyst, this gap is not immediately actionable.
📉 Reward/risk: 2.5:1
🏢 Business Quality: 8/10 - UNH is a diversified healthcare leader with stable earnings, wide moat from scale and Optum assets, and strong execution history.
📊 Valuation: fair — forward PE ~14x on annualized Q1 EPS, near historical lows but in line with peer multiples; EV/EBITDA and FCF yield also in-line; no...
🔮 Catalyst: Consensus estimate revisions following Q1 beat
💰 Entry: $390, stop $370, target $440
📊 Our read: HOLD. Full analysis →
https://stockduty.xyz/s/UNH0622